Literature DB >> 19774384

Microscopic polyangiitis initiated with liver dysfunction, calf pain and fever of unknown origin.

Kei Ohnuma1, Osamu Hosono, Tomoki Katayose, Noritada Yoshikawa, Hiroshi Kawasaki, Takeshi Fujii, Naoki Oyaizu, Hirotoshi Tanaka, Chikao Morimoto.   

Abstract

We report herein a case of microscopic polyangiitis (MPA), presenting onset with a spiking fever, liver/biliary dysfunction without jaundice and calf pain without elevation of serum creatine phosphokinase. During 1 month of careful examinations for initial diagnosis, the patient developed renal dysfunction and pulmonary hemorrhage. Based on the results of positive MPO-ANCA, renal and pulmonary involvements, the patient was diagnosed with MPA and treated with high-dose prednisolone and oral cyclophosphamide. Soon after initiation of the treatment, symptoms such as fever, calf pain, liver/biliary dysfunction and renal dysfunction disappeared with decrease of MPO-ANCA titer to the normal level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19774384     DOI: 10.1007/s00296-009-1121-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  34 in total

Review 1.  ANCA-associated small-vessel vasculitis.

Authors:  Ishak A Mansi; Adriana Opran; Fred Rosner
Journal:  Am Fam Physician       Date:  2002-04-15       Impact factor: 3.292

2.  Microscopic polyangiitis associated with primary biliary cirrhosis.

Authors:  Florenzo Iannone; Paola Falappone; Giovanni Pannarale; Antonietta Gentile; Vito Grattagliano; Michele Covelli; Giovanni Lapadula
Journal:  J Rheumatol       Date:  2003-12       Impact factor: 4.666

3.  Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.

Authors:  D Zauli; L Baffoni; F Cassani; M Fusconi; M Lenzi; G Ballardini; M Luigi; F B Bianchi; E Schrumpf
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

4.  Microscopic polyangiitis atypically presenting with tubulointerstitial nephritis.

Authors:  Y K Wen; M L Chen
Journal:  Clin Nephrol       Date:  2006-05       Impact factor: 0.975

5.  Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.

Authors:  F Seibold; D Slametschka; M Gregor; P Weber
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

6.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.

Authors:  L Guillevin; B Durand-Gasselin; R Cevallos; M Gayraud; F Lhote; P Callard; J Amouroux; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  1999-03

Review 7.  Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.

Authors:  Cees G M Kallenberg; Peter Heeringa; Coen A Stegeman
Journal:  Nat Clin Pract Rheumatol       Date:  2006-12

8.  Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa.

Authors:  C P Goritsas; M Repanti; E Papadaki; N Lazarou; A P Andonopoulos
Journal:  J Hepatol       Date:  1997-03       Impact factor: 25.083

9.  Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.

Authors:  A M Cilursu; J Goeken; R R Olson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

10.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

View more
  2 in total

Review 1.  Microscopic polyangiitis.

Authors:  Sharon A Chung; Philip Seo
Journal:  Rheum Dis Clin North Am       Date:  2010-06-11       Impact factor: 2.670

2.  Pyrexia of unknown origin and pulmonary fibrosis as a presentation of MPO-ANCA associated vasculitis.

Authors:  O Shields; A Shah; B Mann
Journal:  BMJ Case Rep       Date:  2011-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.